¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"disorders, myeloproliferative"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic myeloproliferative disorder
    ¸¸¼º°ñ¼öÁõ½ÄÁúȯ
  • myeloproliferative
    °ñ¼öÁõ½Ä-
  • myeloproliferative disorder
    °ñ¼öÁõ½ÄÁúȯ
  • myeloproliferative syndrome
    °ñ¼öÁõ½ÄÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myeloproliferative
    °ñ¼öÁõ½Ä-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic myeloproliferative disorder
    ¸¸¼º°ñ¼öÁõ½ÄÁúȯ
  • myeloproliferative disorder
    °ñ¼öÁõ½ÄÁúȯ
  • myeloproliferative
    °ñ¼öÁõ½Ä-
  • myeloproliferative syndrome
    °ñ¼öÁõ½ÄÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • DSM-I=Diagnostic and Statistical Manual of Mental Disorders-I
    Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 1ÆÇ
  • SADS, Schedule for Affective Disorders and Schizophrenia
    Á¤µ¿Àå¾Ö¿Í Á¤½ÅºÐ¿­º´ÀÇ Áø´ÜÀ» À§ÇÑ ¸ñ·Ï
  • adrenal disorders
    ºÎ½ÅÀå¾Ö, ºÎ½ÅÁúȯ.
  • genetic disorders
    À¯Àü¼º Àå¾Ö(Áúȯ)(ë¶îîàõ î¡äô)
  • hemostatic disorders
    Ç÷¾×ÀÀ°íÁúȯ
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • platelet function disorders
    Ç÷¼ÒÆÇ±â´ÉÀÌ»óÁúȯ
  • postpartum disorders
    »êÈÄ Àå¾Ö(º´)
  • psychogenic voice disorders
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myeloproliferative disorders
    °ñ¼öÁõ½Ä¼ºÁúȯ
  • chronic myeloproliferative disorder
    ¸¸¼º °ñ¼öÁõ½Ä¼º Áúȯ
  • myeloproliferative
    °ñ¼öÁõ½Ä¼º(Ë­ËàÌ¡ËàËÛ) ÀÇ.
  • myeloproliferative
    °ñ¼öÁõ½Ä¼º(¡­ñòãÖàõ) ÀÇ
  • myeloproliferative disorder
    °ñ¼öÁõ½Ä¼º Áú ȯ(ÍéâÐñòãÖàõòðü´).
  • myeloproliferative disorder
    °ñ¼öÁõ½Ä¼º Áúȯ(¡­ñòãÖàõòðü´)
  • myeloproliferative disorder
    °ñ¼öÁõ½Ä¼º(ÍéâÐñòãÖàõ) Áúȯ
  • myeloproliferative disorder
    °ñ¼öÁõ½Ä¼º Áú ȯ(Ë­ËàÌ¡ËàËṲ̷̂).
  • myeloproliferative syndrome
    °ñ¼öÁõ½Ä¼º Áõ Èıº(ÍéâÐñòãÖàõñøý¦ÏØ).
  • myeloproliferative syndrome
    °ñ¼öÁõ½Ä¼º ÁõÈıº(¡­ ñøý¦ÏØ)
  • myeloproliferative syndrome
    °ñ¼öÁõ½Ä¼º Áõ Èıº(Ë­ËàÌ¡ËàËÛ̷̡˴).
  • adrenal disorders
    ºÎ½ÅÀå¾Ö, ºÎ½ÅÁúȯ.
  • autosomal dominant disorders
    »ó¿°»öü ¿ì¼ºÁúȯ(ßÓæøßäô÷éÐàõòðü´)
  • autosomal recessive disorders
    »ó¿°»öü ¿­¼ºÁúȯ(¡­Ö«àõòðü´)
  • chromosomal disorders
    ¿°»öü Áúȯ (¡­òðü´)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PRAGMATIC pregnancy, rheumatoid arthritis, acromegaly, glucose metabolism disorders, mechanical injury, amyloi...
CMPD chronic myeloproliferative disorder
MPD main pancreatic duct; maximum permissible dose; mean population doubling; membrane potential differe...
MPL maximum permissible level; melphalan; mesiopulpolingual; myeloproliferative leukemia
MPLV myeloproliferative leukemia virus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CMPD Chronic myeloproliferative disorders
MPLV Myeloproliferative Leukemia Virus
MPSV Myeloproliferative Sarcoma Virus
MPD Myeloproliferative disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • American Academy of Craniomandibualr Disorders
    ¹Ì±¹ µÎ°³ÇϾÇÀå¾ÖÇÐȸ
  • myeloproliferative syndrome
    °ñ¼ö Áõ½Ä¼º ÁõÈıº
    Á¶Á÷ Çü¼º»ó ¿¬°üÀÌ ÀÖ´Â Áúȯ ±ºÀ» ÃÑĪÇÏ´Â °ÍÀ¸·Î, ´Ù¾çÇÑ ½Ã±â¿Í ´Ù¾çÇÑ Á¤µµ·Î °ñ¼ö ±¸¼º ¼¼Æ÷ÀÇ Çϳª ȤÀº ±× ÀÌ»óÀÇ ¼¼Æ÷°è»ç °ñ¼ö³» ¹× °ñ¼ö¿Ü·Î Áõ½ÄÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ±× ±¸¼º ¼¼Æ÷¿¡´Â °ñ¼ö±¸Çü, Àû¾Æ±¸Çü, °ÅÇÙ ¼¼Æ÷ÇüÀÇ ¼¼Æ÷ ¿Ü¿¡ ¼¼¸Á°ú °£¿±°è À¯·¡ÀÇ ¼¼Æ÷µµ Æ÷ÇԵȴÙ. À̵éÀÇ Áõ½Ä¼º Áúȯ¿¡´Â ±Þ¼º ¹× ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, Áø¼º ´ÙÇ÷Áõ, °ñ¼ö ÀÌÇü¼º, °ñ¼ö ¼¶À¯Á¾, º»Å¼º ÃâÇ÷¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ, ÀûÇ÷±¸ Áõ°¡¼º °ñ¼öÁõ µîÀÌ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
disorders, myeloproliferative Tumours of certain bone marrow cells including those that give rise to red cells, granulocytes, and platelets. As opposed to the lymphoproliferative disorders.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
myeloproliferative disorders A group of disease states which primarily involve the bone marrow and the production blood cells.
Examples include polycythaemia vera, leukaemia, myelofibrosis and primary thrombocytopenia.
(27 Sep 1997)
myeloproliferative Pertaining to or characterised by unusual proliferation of myelopoietic tissue.
(05 Mar 2000)
myeloproliferative syndromes A group of conditions that result from a disorder in the rate of formation of cells of the bone marrow, including chronic granulocytic leukaemia, erythraemia, myelosclerosis, panmyelosis, and erythraemic myelosis and erythroleukaemia.
(05 Mar 2000)
adjustment disorders Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor.
(12 Dec 1998)
affective disorders A class of mental disorder's characterised by a disturbance in mood.
(05 Mar 2000)
affective disorders, psychotic Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.
(12 Dec 1998)
alcohol-related disorders Mental disorders related or resulting from abuse or mis-use of alcohol.
(12 Dec 1998)
amphetamine-related disorders Disorders related or resulting from use of amphetamines.
(12 Dec 1998)
anxiety disorders Disorders in which anxiety (persistent feelings of apprehension, tension, or uneasiness) is the predominant disturbance.
(12 Dec 1998)
articulation disorders Disorders of speech sound production characterised by substitution, omission, and distortion of sounds.
(12 Dec 1998)
auditory perceptual disorders Disorders of auditory perception manifesting as difficulties with auditory memory, speech perception and sound localization. Lesions are usually in the temporal lobe.
(12 Dec 1998)
bowel disorders and fibre High fibre diets help delay the progression of diverticulosis and, at least, reduce the bouts of diverticulitis. In many cases, it helps reduce the symptoms of the Irritable Bowel Syndrome ( IBS ). It is generally accepted that a diet high in fibre is protective, or at least reduces the incidence, of colon polyps and colon cancer.
(12 Dec 1998)
calcium metabolism disorders Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
gender identity disorders A class of mental disorders characterised by an incongruity between an assigned culturally determined set of attitudes, behaviour patterns, and physical characteristics associated with masculinity or femininity and gender identity.
See: transsexualism.
(05 Mar 2000)
paranoid disorders Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behaviour are consistent with the delusional state.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á